Press Releases
Corbus Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Corbus Pharmaceuticals to Present Pre-Clinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
Corbus Pharmaceuticals Appoints Anne Altmeyer, PhD to Board of Directors
Corbus Presents First Pre-Clinical Data for CRB-913 at the European Association for the Study of Diabetes 2022 Annual Conference
Corbus Pharmaceuticals to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conference
Corbus Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Corbus Presents Latest Preclinical Data for CRB-601 at the New York Academy of Sciences Frontiers in Cancer Immunotherapy Conference
Corbus Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
Corbus Presents First Preclinical Data for CRB-601 at the American Association for Cancer Research (AACR) Annual Meeting
Corbus Pharmaceuticals to Present at the Oppenheimer 32nd Annual Healthcare Conference
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Updates
